Prof. Dr. Mustafa Altınbaş

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
Lung NeoplasmsStomach NeoplasmsNeoplasmsBreast NeoplasmsProstatic NeoplasmsLiver NeoplasmsRectal NeoplasmsKidney NeoplasmsColorectal NeoplasmsOvarian NeoplasmsPainBone NeoplasmsCarcinoma, Small CellCarcinoma, Squamous CellSuperior Vena Cava SyndromeMesotheliomaParaneoplastic SyndromesNeutropenia
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lung Neoplasms 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Stomach Neoplasms 5 publications
  • Neoplasms 5 publications
  • Breast Neoplasms 4 publications
  • Prostatic Neoplasms 3 publications
  • Liver Neoplasms 3 publications
  • Rectal Neoplasms 2 publications
  • Kidney Neoplasms 2 publications
  • Colorectal Neoplasms 2 publications
  • Ovarian Neoplasms 2 publications
  • Pain 2 publications
  • Bone Neoplasms 2 publications
  • Carcinoma, Small Cell 2 publications
  • Carcinoma, Squamous Cell 2 publications
  • Superior Vena Cava Syndrome 2 publications
  • Mesothelioma 2 publications
  • Paraneoplastic Syndromes 2 publications
  • Neutropenia 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceOnkolojisaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLung NeoplasmsExtracted from 8 publications · Model version —From source
  • Publications125 publicationsORCID, Europe PMC, OpenAlexFrom source
  • ORCID0000-0002-8024-2362ORCIDFrom source
  • Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#mustafa-altinbassaglik.gov.tr

Scientific work

Publications on Lung Neoplasms

125 publications

  1. Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

    The Breast, 2026

    DOI 10.1016/j.breast.2026.104936 PMID 42777557 Open-access full textSource: ORCID

  2. Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)

    Clinical Colorectal Cancer, 2026

    DOI 10.1016/j.clcc.2025.10.002 PMID 41198426 1 citation (Europe PMC) Source: ORCID

  3. Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

    Expert review of anticancer therapy, 2026

    DOI 10.1080/14737140.2026.2733826 PMID 42733172 Source: Europe PMC

  4. Baseline 25-hydroxyvitamin D and progression-free survival in de novo metastatic hormone-sensitive prostate cancer: prognostic model development and external validation

    The oncologist, 2026

    DOI 10.1093/oncolo/oyag396 PMID 42836684 Open-access full textSource: Europe PMC

  5. Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072475 PMID 41976774 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  6. Recurrence of gastric cancer with Krukenberg tumor, presenting with a high alpha-fetoprotein level, a case report

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1676891 PMID 41800062 Open-access full textSource: OpenAlex

  7. Integrated assessment of cachexia, body composition, and patient-reported outcomes in unplanned hospitalizations of patients with metastatic cancer (PRO-HAND study).

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.12075 Source: OpenAlex

  8. Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

    Figshare, 2026

    DOI 10.6084/m9.figshare.33717648 Open-access full textSource: OpenAlex

  9. Clinicopathologic Characteristics, Treatment Patterns, and Survival Outcomes in Malignant Mesothelioma: A Population-based SEER Study, 2004-2023

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-8-2 Open-access full textSource: OpenAlex

  10. Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15922 Open-access full textSource: OpenAlex

View all 125 publications